https://www.marketscreener.com/quote/stock/VIR-BIOTECHNOLOGY-INC-66771988/news/Vir-Biotechnology-Completes-Enrollment-of-Phase-2-Chronic-Hepatitis-Delta-SOLSTICE-Trial-Ahead-of-Sc-46094757/?utm_source=telegram&utm_medium=social&utm_campaign=share